Specifically, FCGBP has been associated with amyotrophic lateral sclerosis, where its involvement extends to the facilitation of autoimmune and neuroinflammatory responses.90 Furthermore, heightened levels of FCGBP have been observed in Parkinson’s disease, also emphasizing its role as a pertinent neuroinflammatory marker.91 In this study, we detected upregulated levels in the TBI group in all three comparisons (2.1, 6.0, and 4.3 times, respectively). This evidence concerns the gene FCGBP and Parkinson disease.